CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities
Net income (loss)	$ 2,162	$ (58,327)	$ 32,235	$ (110,376)
Less: net loss from discontinued operations	0	(75)	0	22,048
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Depreciation, amortization and share-based compensation			6,318	5,737
Net realized gains on investment	(4,133)	(12,700)	(24,046)	(25,685)
Total other-than-temporary impairment losses	962	165	2,468	165
Foreign exchange and other losses (gains)	6,536	(7,827)	634	(14,013)
Changes in assets – (increase) decrease:
Reinsurance balances receivable, net			22,200	18,517
Reinsurance recoverable on unpaid losses			(7,334)	(439,142)
Accrued investment income			5,899	8,542
Deferred commission and other acquisition expenses			21,507	159,524
Funds withheld receivable			53,205	(82,459)
Other assets			(3,589)	(5,843)
Changes in liabilities – increase (decrease):
Reserve for loss and loss adjustment expenses			(476,655)	87,772
Unearned premiums			(59,250)	(518,542)
Accrued expenses and other liabilities			(21,256)	(53,686)
Net cash used in continuing operations			(447,664)	(947,441)
Net cash used in discontinued operations			0	(1,842)
Net cash used in operating activities			(447,664)	(949,283)
Cash flows from investing activities:
Purchases of fixed maturities			(355,966)	(1,917,030)
Purchases of other investments			(45,279)	(7,450)
Proceeds from sales of fixed maturities	71,857	136,347	477,358	845,962
Proceeds from maturities, paydowns and calls of fixed maturities			451,380	1,766,914
Proceeds from sale and redemption of other investments			1,786	858
Other, net			(602)	3,253
Net cash provided by investing activities for continuing operations			528,677	692,507
Net cash used in investing activities for discontinued operations			0	(6,113)
Net cash provided by investing activities			528,677	686,394
Cash flows from financing activities:
Repurchase of common shares			(1)	(18)
Net cash used in financing activities			(1)	(18)
Effect of exchange rate changes on foreign currency cash, restricted cash and equivalents			1,605	(1,269)
Net increase (decrease) in cash, restricted cash and cash equivalents			82,617	(264,176)
Cash, restricted cash and cash equivalents, beginning of period			107,278	337,102
Cash, restricted cash and cash equivalents, end of period	189,895	72,926	189,895	72,926
Reconciliation of cash and restricted cash reported within Condensed Consolidated Balance Sheets:
Cash and cash equivalents, end of period	91,721	39,755	91,721	39,755
Restricted cash and cash equivalents	98,174	33,171	98,174	33,171
Total cash, restricted cash and cash equivalents, end of period	$ 189,895	$ 72,926	189,895	72,926
Investments transferred out related to Partial Termination Amendment and Commutation
Non-cash investing activities
Investments transferred out			0	599,613
Investments transferred out for transactions under remaining AmTrust Quota Share business
Non-cash investing activities
Investments transferred out			0	812,068
Discontinued Operations
Non-cash investing activities
Investments transferred out			$ 0	$ 68,262